Halozyme Therapeutics Inc (NASDAQ:HALO)

51.67
Delayed Data
As of 3:59pm ET
 -0.17 / -0.33%
Today’s Change
32.00
Today|||52-Week Range
59.46
-9.19%
Year-to-Date

Today’s Trading

Previous close51.84
Today’s open51.41
Day’s range51.02 - 51.70
Volume22,969
Average volume (3 months)1,208,247
Market cap$7.1B
Data as of 3:59pm ET, 02/07/2023

Growth & Valuation

Earnings growth (last year)+202.13%
Earnings growth (this year)-51.93%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+65.67%
P/E ratio34.9
Price/Sales13.32
Price/Book36.76

Competitors

----
----
----
CRSPCRISPR Therapeutics ...+0.17+0.31%
Data as of 4:00pm ET, 02/07/2023

Financials

Next reporting dateFebruary 21, 2023
EPS forecast (this quarter)$0.30
Annual revenue (last year)$443.3M
Annual profit (last year)$402.7M
Net profit margin90.84%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts